Yes, and being Young Endocrinologists and Diabetologists, I expect drinking this eveningIf the conference doesn't begin until tomorrow, is this from a pre-meeting going on?
Yes, and being Young Endocrinologists and Diabetologists, I expect drinking this eveningIf the conference doesn't begin until tomorrow, is this from a pre-meeting going on?
Just for clarity: Neuropathy, retinopathy and nephropathy are the microvascular complications of diabetes.Wasn't talking about Micro and Macrovascular complications. Looking at nervous system, retinal and kidneys. Slightly different spin. I've asked for the data - will hopefully get a copy of the slides @phoenix. Vascular seems to be ignored. Doesn't look like particularly new data though.
That's important. Vast difference between 4-20 and 7-10 !Example given shows high as ranging 4-20 and low as ranging 7-10. Also stated that higher average with lower variability better than lower average with higher variability.
That's important. Vast difference between 4-20 and 7-10 !
I'm sure we are all learning from these forums. I don't know about a controversy but according to the WHO (World Health Organisation):-Thanks for that @Dark Horse. I clearly need to do more reading to pass my diabetology examsAlways good to be reminded of the extent of our knowledge. Original post has been updated to reflect your comments.
On further reading it seems as though there is some controversy as to whether Neuropathy is a truly microvascular complication or whether there are other factors? Would you be able to comment on those theories?
One of the drivers of the micro-vascular and polyol pathway driven complications seems to be variation in BG levels.Is this a T1 thing, or am I being thick, because I still don't know what it means. Please can someone explain?